Dry Eye Syndrome
Ophthalmology
Dry Eye Syndrome is treated with 11 medications in our database, including Tyrvaya, Xiidra, Lifitegrast, TRYPTYR, CEQUA, and 6 more. 9 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Oyster Point, Bausch Lomb, Azurity, Sun, Amcon and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Dry Eye Syndrome treatment below.
What help exists for Dry Eye Syndrome
11
drugs indexed
10
with copay cards
10
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Dry Eye Syndrome
11 totalGloStrips
Fluorescein Sodium · Amcon
Eysuvis
loteprednol etabonate · Alcon
🎟💙Lifitegrast
Lifitegrast · Bausch Lomb
🎟💙Tyrvaya
varenicline · Oyster Point
🎟💙Xiidra
Lifitegrast · Bausch Lomb
🎟💙VEVYE
cyclosporine ophthalmic solution · Harrow
🎟💙MIEBO
Perfluorohexyloctane · Bausch Lomb
🎟💙CEQUA
cyclosporine · Sun
🎟💙RESTASIS
cyclosporine · AbbVie
🎟💙TRYPTYR
Acoltremon · Azurity Pharmaceuticals
🎟💙Restasis MultiDose
cyclosporine · AbbVie
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Dry Eye Syndrome drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Showing 10 of 11 PA rules for Dry Eye Syndrome drugs. View individual drug pages for complete PA detail.